4925 Results

People

  1. Giralt
    Giralt
  2. Berger
    Berger
  3. Morrow
    Morrow
  4. Horwitz
    Horwitz
  5. Ladanyi
    Ladanyi
  6. Lee
    Lee
  7. Adusumilli
    Adusumilli
  8. Hyman
    Hyman
  9. Perales
    Perales
  10. Solit
    Solit

Groups

  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)
  7. Center for Hematologic Malignancies (764)
  8. Hematologic Malignancies, Division of (714)
  9. Department of Pathology and Laboratory Medicine (653)
  10. Population Sciences Research Program (632)
  1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Integrated analysis of multidimensional genomic data on CALGB 40601 (Alliance), a randomized neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer
    Meeting Abstract

    Tanioka, M.; Fan, C.; Carey, L. A.; Hyslop, T.; Pitcher, B. N.; Parker, J. A.; Hoadley, K. A.; Henry, N. L.; Tolaney, S.; Dang, C.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Phase 3 study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer who have stable brain metastases previously treated with an anthracycline, a taxane, and capecitabine
    Meeting Abstract

    Tripathy, D.; Tolaney, S.; Seidman, A. D.; Anders, C. K.; Ibrahim, N.; Rugo, H. S.; Twelves, C. J.; Cortes, J.
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Scalp cooling alopecia prevention trial (SCALP) for patients with early stage breast cancer
    Meeting Abstract

    Nangia, J. R.; Wang, T.; Niravath, P. A.; Otte, K.; Osborne, C. R.; Papish, S.; Holmes, F. A.; Abraham, J.; Goldfarb, S.; Courtright, J. G.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Impact of radiotherapy on complications and patient-reported satisfaction with breast reconstruction: Findings from the prospective multicenter MROC study
    Meeting Abstract

    Jagsi, R.; Momoh, A. O.; Qi, J.; Hamill, J. B.; Billig, J.; Kim, H. M.; Pusic, A. L.; Wilkins, E. G.
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Genetic counseling, germline genetic testing, and impact of results in patients with newly diagnosed breast cancer
    Meeting Abstract

    Katz, S. J.; Morrow, M.; Jagsi, R.; Kurian, A.
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Prognostic associations of tumor-infiltrating lymphocytes (TIL) in metastatic HER2-positive breast cancer (BC) treated with trastuzumab and pertuzumab: A secondary analysis of the CLEOPATRA study
    Meeting Abstract

    Luen, S.; Salgado, R.; Stephen, F.; Peter, S.; Jennifer, E. W.; Emma, C.; Astrid, K.; Sandra, S. M.; Jose, B.; Stefan, M.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Are there patients with T1-T2, node-negative breast cancer who are high-risk for locoregional recurrence?
    Meeting Abstract

    Mamtani, A.; Patil, S.; Stempel, M.; Morrow, M.
    Cancer Research (2017)

    Fulltext@MSK | Save
  • A pilot study of radiation (RT) and CTLA4-mediated checkpoint blockade with tremelimumab for the treatment of breast cancer brain metastases (BCBM)
    Meeting Abstract

    McArthur, H. L.; Beal, K.; Halpenny, D.; Henrich, M.; Patil, S.; Young, R.; Kaley, T.; Hamilton, N.; Hudis, C.; Wolchok, J.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Impact of magnetic resonance imaging on conversion from wide local excision to mastectomy in patients with ductal carcinoma in situ: First results from the ECOG-ACRIN 4112 prospective study
    Meeting Abstract

    Lehman, C. D.; Gatsonis, C.; Greco, E.; Khan, S. A.; Sparano, J. A.; Solin, L. J.; Badve, S. S.; Corsetti, R. L.; Rahbar, H.; Spell, D. W.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save